Detection of DNA polymorphisms and point mutations of high-affinity Nerve Growth Factor receptor (TrkA) in human neuroblastoma

International Journal of Oncology

Volumn 14, Issue 5, 1999, Pages 935-938

  Scaruffi, Paola ^a,b   Cusano, Roberto ^a   Dagnino, Monica ^a,b   Tonini, Gian Paolo ^b,c  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ADVANCED BIOTECHNOLOGY CENTER   (Italy)

Author keywords

Mutations; Nerve growth factor; Neuroblastoma; Receptor tyrosine kinase; TrkA

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; RNA;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; GENETIC POLYMORPHISM; GENETICS; HUMAN; NEUROBLASTOMA; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

HUMANS; NEOPLASM STAGING; NEUROBLASTOMA; POINT MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0033129119     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.5.935     Document Type: Article

References (24)

1. Pulciani S, Santos E, Lauver AV, Long LK, Aaronson SA and Barbacid M: Oncogenes in solid human tumours. Nature 300: 539-542, 1982.
2. Martin-Zanca D, Hughest SH and Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319: 743-748, 1986.
3. Martin-Zanca D, Oskam R, Mitra G, Copeland T and Barbacid M: Molecular and biochemical characterisation of the human trk proto-oncogene. Mol Cell Biol 9: 24-33, 1989.
4. Azar CG, Scavarda NJ, Reynolds CP and Brodeur GM: Multiple defects of the nerve growth factor receptor in human neuroblastoma. Cell Growth Differ 1: 421-428, 1990.
5. Chen J, Chattopadhyay B, Venkatakrishnan G and Ross AH: Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines. Cell Growth Differ 1: 79-85, 1990.
6. Poluha W, Poluha DK and Ross A: Trka neurogen receptor regulates differentiation of neuroblastoma cells. Oncogene 10: 185-189, 1995.
7. Nakagawara A, Arima M, Azar CG, Scavarda NJ and Brodeur GM: Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 62: 1364-1368, 1992.
8. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB and Garret MB: Association between high levels of expression of the trk gene and favourable outcome in human neuroblastoma. N Engl J Med 328: 847-854, 1993.
9. Suzuki T, Bogenmann E, Shimada H, Stram D and Seeger RC: Lack of high-affinity nerve growth factor receptor in aegressive neuroblastomas. J Natl Cancer Inst 85: 377-384, 1993.
10. Borrello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, Pilotti S, Rizzetti MG, Mondellini P, De Bernardi B, Di Martino D, Garaventa A, Brisigotti M and Tonini GP: TRK and RET proto-oncogene expression in human neuroblastoma specimens: high frequency of TRK expression in non-advanced stages. Int J Cancer 54: 540-545, 1993.
11. Kogner P, Barbany G, Dominici C, Castello MA, Raschellà G and Persson H: Coexpression of messenger RNA for TRK proto-oncogene and low affinity nerve growth factor in neuroblastoma with favourable prognosis. Cancer Res 53: 2044-2050, 1993.
12. Nakagawara A, Azar CG, Scavarda NJ and Brodeur GM: Expression and function of Trk-B and BDNF in human neuroblastomas. Mol Cell Biol 14: 59-67, 1994.
13. Indo Y, Tsuruta M, Hayashida Y, Karim MA, Ohta K, Kawano T, Mitsubuchi H, Tonoki H, Awaya Y and Matsuda I: Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anidrosis. Nat Genet 13: 485-487, 1996.
14. Brodeur GM, Seeger RC, Barret A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, Haase G, Hartmann O, Hayes FA, Helson L, Kemshead J, Lampert F, Ninane J, Ohwara H, Philip T, Pinkertan CR, Prithchard J, Sawada T, Siegel S, Smith EI, Tsuchida Y and Vaute PA: International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881, 1988.
15. Chomczynski P and Sacchi N: Single-step of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
16. Corrias MV, Cornaglia-Ferraris P, Di Martino D, Stenger AM, Lanino E, Boni L and Tonini GP: Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients. Anticancer Res 10: 897-902, 1990.
17. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning. A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, New York, 1989.
18. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517, 1975.
19. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M and Chao M: Expression and structure of the human NGF receptor. Cell 47: 545-554, 1986.
20. Feinberg AP and Vogelstein BA: A technique for radiolabeling DNA restriction endonuclease fragment to high specific activity. Anal Biochem 132: 6-13, 1983.
21. Kozma SC, Redmond MS, Xiao-Chang F, Saurer SM, Groner B and Hynes NE: Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences. EMBO J 7: 147-154, 1988.
22. Ziemiecki A, Müller RG, Xiao-Chang F, Hynes NE and Kozma S: Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a. EMBO J 9: 191-196, 1990.
23. Greco A, Mariani C, Miranda C, Pagliardini S and Pierotti MA: Characterization of the NTRKI genomic region involved in chromosomal rearrangements generating TRK oncogenes. Genomics 18: 397-400, 1993.
24. Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M and Pierotti MA: The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol 15: 6118-6127, 1995.